Impel Pharmaceuticals (FRA:84P) Days Sales Outstanding : 120.66 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Impel Pharmaceuticals Days Sales Outstanding?

Impel Pharmaceuticals's average Accounts Receivable for the three months ended in Sep. 2023 was €6.22 Mil. Impel Pharmaceuticals's Revenue for the three months ended in Sep. 2023 was €4.71 Mil. Hence, Impel Pharmaceuticals's Days Sales Outstanding for the three months ended in Sep. 2023 was 120.66.

The historical rank and industry rank for Impel Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

FRA:84P' s Days Sales Outstanding Range Over the Past 10 Years
Min: 115.62 Med: 432.81 Max: 738.74
Current: 115.62

During the past 4 years, Impel Pharmaceuticals's highest Days Sales Outstanding was 738.74. The lowest was 115.62. And the median was 432.81.

FRA:84P's Days Sales Outstanding is ranked worse than
71.51% of 888 companies
in the Biotechnology industry
Industry Median: 72.545 vs FRA:84P: 115.62

Impel Pharmaceuticals's Days Sales Outstanding declined from Sep. 2022 (157.19) to Sep. 2023 (120.66).

Impel Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Impel Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impel Pharmaceuticals Days Sales Outstanding Chart

Impel Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

739.26

125.67

Impel Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Sales Outstanding	Get a 7-Day Free Trial											157.19	127.54	144.07	91.17	120.66

Competitive Comparison of Impel Pharmaceuticals's Days Sales Outstanding

For the Biotechnology subindustry, Impel Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Impel Pharmaceuticals's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Impel Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Impel Pharmaceuticals's Days Sales Outstanding falls into.

Impel Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Impel Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (1.197	+	7.027)	/	2 )	/	11.943	*	365
=	4.112					/	11.943	*	365
=	125.67

Impel Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding (Q: Sep. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Sep. 2023 ))	/	count )	/	Revenue (A: Sep. 2023 )	*	Days in Period
=	( (6.277	+	6.171)	/	2 )	/	4.707	*	365 / 4
=	6.224					/	4.707	*	365 / 4
=	120.66

Impel Pharmaceuticals (FRA:84P) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Impel Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Impel Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Impel Pharmaceuticals (FRA:84P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Impel Pharmaceuticals Inc (FRA:84P) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

IMPLQ:USA

Address

201 Elliott Avenue West, Suite 260, Seattle, WA, USA, 98119

Website

https://www.impelpharma.com

Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. The company is developing an approach to drug delivery that administers specific formulations of drugs deep into the vascular-rich upper nasal space, a gateway for therapeutic administration of a versatile range of molecules and formulations.

Impel Pharmaceuticals (FRA:84P) Headlines

No Headlines